Neuronetics Q1 revenue $32M (+84% YoY); narrows FY guidance; CFO to retire March 2026

Neuronetics, Inc.

2025-Q1 EPS reported -$0.21 revenue$31,975,000

Q1 revenue $32.0M, up 84% YoY driven by Greenbrook acquisition; net loss $(12.7)M vs $(7.9)M
U.S. clinic revenue $18.7M (post-Greenbrook); NeuroStar system revenue $2.8M (-14%)
CFO Steve Furlong to retire March 31, 2026; search for successor underway
Full-year 2025 revenue guidance narrowed to $149M-$155M (prev $145M-$155M)
Cash $20.2M; expects Q3 2025 cash flow positive; Q2 cash usage <$5M

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stephen Furlong

Chief Financial Officer

STIM · Neuronetics, Inc.

Effective: 2026-03-31
Filed: May 6, 2025, 7:59 PM ET

On May 6, 2025, the Company announced that Stephen Furlong, who has served as Chief Financial Officer since 2019, will retire on March 31, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.99

Stephen Furlong departed as Chief Financial Officer at Neuronetics, Inc..

Action: will retire
Role: Chief Financial Officer

Exact text from the filing

On May 6, 2025, the Company announced that Stephen Furlong, who has served as Chief Financial Officer since 2019, will retire on March 31, 2026.

View on SEC.gov

Neuronetics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-113283

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.